Top Cardiovascular Update CMS Critical Care Content for Sun.Jul 28, 2024

Sun.Jul 28, 2024

Antiretroviral Abacavir Linked With Cardiovascular Events in REPRIEVE Trial

Med Page Today

JULY 28, 2024

(MedPage Today) -- People with HIV who took the antiretroviral drug abacavir (Ziagen) had an increased risk of major adverse cardiovascular events (MACE), according to an exploratory analysis of the REPRIEVE trial. Past use of abacavir increased.

Post-stent chest pain, revisited

Heart Sisters

JULY 28, 2024

Heart patients with persistent or recurrent post-stent chest pain present “an unmet clinical need”, according to the European Journal of Cardiology.

Chest Pain

Chest Pain Stents Stent Heart Disease

Sexual Dysfunction Common Among Patients with Psoriatic Arthritis

HCPLive

JULY 28, 2024

Most men (91.7%) and women (72.7%) with psoriatic arthritis exhibited sexual dysfunction.

Potential new therapeutic target for HFpEF

Nature Reviews - Cardiology

JULY 28, 2024

Nature Reviews Cardiology, Published online: 29 July 2024; doi:10.1038/s41569-024-01066-2 A new small-molecule inhibitor of vasohibins reduces myocardial stiffness and improves diastolic relaxation in a rat model of HFpEF.

Edwards Acquires JenaValve and Endotronix, Expands into Aortic Regurgitation and Heart Failure

CardiacWire

JULY 28, 2024

Edwards Lifesciences is going all-in on structural heart and heart failure, acquiring aortic valve-maker JenaValve Technology and implantable heart failure monitor company Endotronix for $1.2B and up to $445M in milestone payments. These two acquisitions could impact Edwards’ structural heart and heart failure portfolios in unique and meaningful ways… JenaValve’s Trilogy TAVR system doesn’t yet have FDA approval, but is CE Marked for both aortic regurgitation and aortic stenosis, which is notabl

Heart Failure

Heart Failure Aortic TAVR Critical Care

Mortality and cardiovascular events in diabetes mellitus patients at dialysis initiation treated with glucagon-like peptide-1 receptor agonists

Cardiovascular Diabetology

JULY 28, 2024

Glucagon-like Peptide-1 Receptor Agonists (GLP-1RAs) have demonstrated efficacy in improving mortality and cardiovascular (CV) outcomes. However, the impact of GLP-1RAs therapy on cardiorenal outcomes of diabe.

Diabetes

Diabetes Outcomes Research

Surgical intervention for lung cancer in patients aged 75 and above: potential associations with increased mortality rates—a single-center observational study

Journal of Cardiothoracic Surgery

JULY 28, 2024

Lung cancer, which is diagnosed two to three times more frequently in patients over the age of 70, is a leading cause of cancer-specific mortality. Given the elevated risk of morbidity and mortality, surgical.

Cancer

Cancer Research

Ultrasound parameters of arteries and heart in normal fetuses

Cardiovascular Ultrasound

JULY 28, 2024

Currently, no normal ultrasound data of the fetuses during the 20–40 gestation have been obtained for references of fetal growth and development. If such ultrasound data existed for prenatal diagnosis of possi.

Ultrasound

Ultrasound Research

More Trending

Ultrasound parameters of arteries and heart in normal fetuses

Cardiovascular Ultrasound

JULY 28, 2024

Ultrasound

Ultrasound Research

Extensive myocardial calcifications: a systematic literature review of a rare pathological phenomenon

Frontiers in Cardiovascular Medicine

JULY 28, 2024

IntroductionMyocardial calcifications (MC) represent a relatively rare pathological process, which may accompany different cardiovascular conditions and can be broadly categorized as dystrophic or metastatic. Myocardial infarction (MI) has been traditionally regarded as the main cause of MC overall; however, no updated comprehensive data on the relative incidence of different forms of MC is available.

Myocardial Infarction

Myocardial Infarction Kidney Disease Heart Disease

Long-term management of recurrent in-stent restenosis

Cardiology Update

JULY 28, 2024

A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. With minimal data and guidelines available for repeat percutaneous coronary interventions (PCI), this research offers valuable guidance for clinicians.

Stents

Stents Stent Cardiovascular Interventions Research

Delgocitinib Cream Effective Over 16 Weeks for Chronic Hand Eczema

HCPLive

JULY 28, 2024

These findings support delgocitinib’s clinical benefit as a possible medication option for individuals with moderate to severe chronic hand eczema.

Lessons from PROMINENT and prospects for pemafibrate

Cardiovascular Diabetology

JULY 28, 2024

The neutral result of the PROMINENT trial has led to questions about the future for pemafibrate. This commentary discusses possible reasons for the lack of benefit observed in the trial. There were, however, i.